Skip to content

Rhizome AI — Analytics & Data

from $0

Rhizome AI (Analytics & Data): Rhizome AI is a hallucination-free regulatory AI that answers questions with cited docs from FDA, EMA, and health authorities. Pricing: from $0. (data verified August 2026)

Transparency: if you buy through our links we may earn a commission, at no extra cost to you. Rankings cannot be bought. How we rate tools

About Rhizome AI

What is Rhizome AI?

Rhizome AI is a regulatory intelligence platform that helps life sciences professionals know what the FDA, EMA, and other health authorities think. It searches over 47.7 million documents from 19 countries and organizations, and instantly answers each question with up to 1,000 citations from primary sources, eliminating hallucinations.

Who is it for?

It is designed for regulatory affairs managers, clinical development teams, and medical writers who need accurate, traceable answers for submissions, strategy, and due diligence. It is not for general legal or non-regulated research.

Real use cases

Users ask complex questions like designing Phase 1 oncology trials for FDA and EMA compliance. Rhizome AI reads hundreds of sources, cites each fact, and drafts a full briefing document, saving hours of manual research.

Key features

  • Up to 1,000 citations per answer — Get comprehensive responses backed by primary sources.
  • Hallucination-free — Each fact is tied to a verified document, reducing risk of misinformation.
  • Traceable citations — Jump directly to the source page for full context and auditability.
  • Multi-agency coverage — Includes FDA, EMA, and 17 other English-speaking health authorities.
  • Document drafting — Automatically generates briefing documents from your queries.
  • Real-time index updates — Content indexed through Aug 2026, covering the latest regulations.

SaaSpartout Score

6.9 /10
Ease of use 7.5
Features depth 8.5
Value for money 7.0
Support quality 6.5
Integrations 5.5
Scalability 7.5
Documentation 6.0
Onboarding speed 7.0

Editorial score from our review methodology — not user ratings.

◆ AI advisor — 30 seconds, no signup
Why are you looking at Analytics & Bi tools today?

Prefer the full AI advisor? Open it here →

Rhizome AI Pricing

Rhizome AI pricing: from $0.

For comparison: the median starting price in Analytics & Data is $39/month, measured across 274 tools we track. See the full SaaS Pricing Index →

Free

$0/month — 10 messages/month across FDA, EMA, and other English HAs. Start for free.

Project

$400/month — Immediate flexible access, unlimited usage, upgraded agent, 2x faster response times.

Professional

$4,000/year — Best-value single-seat access, everything in Project plus 2 months free.

Business

$30,000/year — 5 seats, monthly office hours, invoice-based pricing, SSO, custom security requirements.

Enterprise

Custom — Adds non-English HAs (South Korea, Japan, China, Argentina, etc.). Contact us.

Free trial available with the free tier. Book a demo for more.

Find the right tool for you with our AI advisor →

Frequently asked questions

Is Rhizome AI free?
Yes, Rhizome AI offers a free tier with 10 messages per month. Paid plans start at $400/month for Project.
How much does Rhizome AI cost?
Rhizome AI pricing starts at $0 for free tier, $400/month for Project, $4,000/year for Professional, $30,000/year for Business, and custom for Enterprise.
What is Rhizome AI used for?
It is used by regulatory affairs professionals to get cited answers from FDA and EMA documents, helping with regulatory strategy, clinical trial design, and submission preparation.
Does Rhizome AI have alternatives?
Alternatives include regulatory intelligence tools like Veeva Vault, IQVIA Regulatory, and proprietary in-house solutions. However, Rhizome AI's cited, hallucination-free AI is unique.
What are the limitations of Rhizome AI?
The free tier has only 10 messages per month. Enterprise features for non-English health authorities require a custom plan.

Don’t take our word for it — ask your AI about Rhizome AI

Gemini ChatGPT Claude Perplexity Grok